Translation & Genetic Code

Translation is the ribosome-driven decoding of mRNA into a polypeptide, governed by the triplet genetic code. This topic links molecular biology with pharmacology (protein-synthesis inhibitors) and microbiology (antibiotic mechanisms), making it a recurring source of mixed-concept NEET PG questions.

The Genetic Code: definition and properties

The genetic code is the set of rules by which a sequence of nucleotide triplets (codons) in mRNA specifies amino acids during protein synthesis. There are 4³ = 64 codons: 61 sense codons encoding 20 amino acids plus 3 stop (nonsense) codons.

Property	Meaning	Exam pearl
Triplet	3 bases = 1 codon	64 combinations from 4 bases
Non-overlapping	Each base read once, in one codon only	Frameshift if base inserted/deleted
Comma-less	No punctuation between codons	Read continuously from start codon
Degenerate (redundant)	One amino acid coded by >1 codon	Leu, Arg, Ser have 6 codons each
Unambiguous (specific)	One codon = only one amino acid	No codon codes two amino acids
Universal (nearly)	Same code across species	Exceptions: mitochondria, some protozoa
Has polarity	Read 5′ → 3′	Codon written 5′→3′

High-yield: The code is degenerate but unambiguous — a single amino acid may have several codons, but a single codon never codes for more than one amino acid. This is the single most-tested conceptual statement on the genetic code.

Degeneracy and the wobble hypothesis

Degeneracy mostly resides in the third base of the codon (the "wobble" position). Crick's wobble hypothesis explains how a single tRNA can recognise multiple codons differing only at the 3′ base. The first base of the anticodon (5′ end) can form non-standard pairs.

• Inosine (I) at the wobble position is especially promiscuous — it can pair with U, C, or A.
• Wobble reduces the number of tRNAs needed (a cell needs ~31 tRNAs, not 61).

High-yield: Wobble occurs at the 3′ position of the codon / 5′ position of the anticodon. Inosine in the anticodon is the classic wobble base.

Start and stop codons

• Initiator codon: AUG → codes Methionine (eukaryotes) and N-formylmethionine (fMet) in prokaryotes. Rarely GUG/UUG act as alternative initiators in bacteria.
• Terminator (nonsense / stop) codons: UAA, UAG, UGA. They code for no amino acid; recognised by release factors, not tRNA.

Mnemonic for stop codons: U Are Annoying, U Are Gone, U Go Away (UAA, UAG, UGA). Or eponymous: UAG = amber, UAA = ochre, UGA = opal/umber.

The translation machinery

Ribosome structure

Feature	Prokaryote (70S)	Eukaryote (80S)
Small subunit	30S (16S rRNA + 21 proteins)	40S (18S rRNA)
Large subunit	50S (23S + 5S rRNA)	60S (28S + 5.8S + 5S rRNA)
Peptidyl transferase	23S rRNA (a ribozyme)	28S rRNA
Initiator tRNA	fMet-tRNA	Met-tRNA
Key drug targets	30S & 50S antibiotics	cycloheximide (60S)

High-yield: Peptidyl transferase is a ribozyme — its catalytic activity resides in the 23S rRNA (prokaryotes), not in protein. This proves RNA can catalyse peptide-bond formation.

Each ribosome has three sites:

• A site (Aminoacyl) — accepts incoming aminoacyl-tRNA.
• P site (Peptidyl) — holds the growing peptide chain.
• E site (Exit) — discharges deacylated tRNA.

tRNA and aminoacyl-tRNA synthetases

tRNA is the adaptor (Crick's "adaptor hypothesis") that physically bridges codon and amino acid. It is cloverleaf-shaped in 2D, L-shaped in 3D, ~74–95 nucleotides, with the invariant 3′-CCA terminus bearing the amino acid and an anticodon loop.

Aminoacyl-tRNA synthetases (one per amino acid, ~20 enzymes) charge tRNAs:

Amino acid + tRNA + ATP → Aminoacyl-tRNA + AMP + PPi

• Reaction is driven by ATP → AMP + PPi (consumes 2 high-energy bonds).
• These enzymes provide a second proofreading / editing step ("second genetic code") ensuring fidelity — they discriminate between similar amino acids (e.g., Ile vs Val).

High-yield: Aminoacyl-tRNA synthetases use ATP hydrolysed to AMP + PPi (not ADP). The aminoacyl-tRNA bond is a high-energy ester linkage that later drives peptide-bond formation.

Steps of translation

Translation proceeds in three phases: Initiation → Elongation → Termination, followed by post-translational processing.

1. Initiation

Prokaryotes:

1. 30S subunit binds mRNA; the Shine-Dalgarno sequence (purine-rich, upstream of AUG) base-pairs with 16S rRNA to position the start codon.
2. fMet-tRNA enters the P site directly, aided by initiation factors IF-1, IF-2 (GTP-dependent), IF-3.
3. 50S subunit joins → 70S initiation complex.

Eukaryotes:

1. The 40S–Met-tRNA complex binds the 5′ cap and scans to the first AUG (Kozak sequence context).
2. Requires many eIFs; eIF-2 (GTP) delivers initiator tRNA.
3. 60S subunit joins → 80S complex.

High-yield: Prokaryotes use the Shine-Dalgarno sequence and fMet; eukaryotes use the 5′ m⁷G cap + scanning (Kozak) and plain Met. eIF-2 is the eukaryotic GTP-dependent initiator-tRNA carrier and a major translational control point.

2. Elongation

A repeating cycle in three steps:

1. Codon recognition / decoding: Incoming aminoacyl-tRNA delivered to the A site by EF-Tu (GTP) in prokaryotes / eEF-1 in eukaryotes. GTP hydrolysed.
2. Peptide bond formation: Catalysed by peptidyl transferase (23S rRNA ribozyme) — peptide transferred from P-site tRNA to A-site amino acid.
3. Translocation: Ribosome moves one codon along mRNA (5′→3′); peptidyl-tRNA shifts A→P, deacylated tRNA P→E. Driven by EF-G (translocase, GTP) in prokaryotes / eEF-2 in eukaryotes.

Decoding (EF-Tu) → Transpeptidation (peptidyl transferase) → Translocation (EF-G) → repeat.

High-yield: EF-2 (eEF-2 / prokaryotic EF-G) is the translocase inactivated by diphtheria toxin and Pseudomonas exotoxin A via ADP-ribosylation, halting eukaryotic protein synthesis.

3. Termination

• A stop codon (UAA/UAG/UGA) enters the A site; no tRNA matches.
• Release factors recognise it: prokaryotes — RF-1 (UAA, UAG), RF-2 (UAA, UGA), RF-3 (GTP); eukaryotes — eRF-1 (all three) + eRF-3.
• Peptidyl transferase now adds water → hydrolyses the peptide from tRNA, releasing the polypeptide. Ribosome dissociates.

Energetics

Total cost per amino acid added ≈ 4 high-energy phosphate bonds: 2 in charging the tRNA (ATP→AMP+PPi) + 1 GTP at decoding + 1 GTP at translocation.

Post-translational modifications (brief)

Folding (chaperones), proteolytic cleavage (proinsulin → insulin), glycosylation, phosphorylation, hydroxylation (proline/lysine in collagen — needs vitamin C), γ-carboxylation (vitamin K–dependent clotting factors). These are frequent crossover MCQs.

Inhibitors of translation — pharmacology crossover

This is the most heavily tested clinical link. Selective toxicity of antibiotics depends on targeting the 70S bacterial ribosome while sparing the host 80S ribosome.

Drug / toxin	Target	Mechanism	Specificity
Streptomycin / aminoglycosides	30S	Misreading of mRNA, blocks initiation	Prokaryote
Tetracyclines	30S	Block aminoacyl-tRNA binding to A site	Prokaryote
Chloramphenicol	50S	Inhibits peptidyl transferase	Prokaryote
Macrolides (erythromycin, clarithromycin), clindamycin	50S	Block translocation (bind 23S rRNA, exit tunnel)	Prokaryote
Linezolid	50S (23S)	Prevents 70S initiation complex formation	Prokaryote
Cycloheximide	60S	Inhibits peptidyl transferase (lab tool)	Eukaryote
Puromycin	A site (both)	tRNA analogue → premature chain release	Both 70S & 80S
Diphtheria toxin / Pseudomonas exotoxin A	eEF-2	ADP-ribosylation of EF-2 → blocks translocation	Eukaryote
Ricin	60S (28S rRNA)	N-glycosidase, depurinates rRNA	Eukaryote
Shiga toxin / verotoxin	60S (28S rRNA)	Depurinates rRNA (like ricin)	Eukaryote

High-yield: Chloramphenicol = peptidyl transferase (50S); Erythromycin = translocation (50S); Tetracycline = A-site / 30S; Aminoglycosides = misreading + 30S; Cycloheximide = 60S (eukaryotic only). These five distinctions are repeatedly examined.

High-yield: Puromycin acts on both prokaryotic and eukaryotic ribosomes because it mimics aminoacyl-tRNA — hence it is not therapeutically selective but is a classic research probe.

Mnemonic — "Buy AT 30, CELL at 50": Aminoglycosides + Tetracyclines → 30S; Chloramphenicol, Erythromycin (macrolides), Lincosamides (clindamycin), Linezolid → 50S.

Exceptions to universality

• Mitochondrial code differences: In human mitochondria UGA = Tryptophan (not stop); AGA/AGG = stop (not Arg); AUA = Met (not Ile).
• Some ciliated protozoa read UAA/UAG as glutamine.
• Selenocysteine (the 21st amino acid) is inserted at a UGA codon read in a special SECIS-element context (e.g., glutathione peroxidase, deiodinases).
• Pyrrolysine (22nd) at UAG in some archaea.

High-yield: Selenocysteine uses the stop codon UGA recontextualised by a SECIS element — a favourite "exception" MCQ.

Mutations relating to the code

Mutation	Effect on protein
Silent (synonymous)	No change (degeneracy) — usually 3rd base
Missense	One amino acid changed (e.g., sickle cell: Glu→Val)
Nonsense	Codon → stop → truncated protein (e.g., β⁰-thalassaemia)
Frameshift (insertion/deletion not in 3s)	Reading frame shifted → garbled downstream protein
Splice-site	Abnormal mRNA processing

High-yield: Sickle cell anaemia = missense (GAG→GTG, Glu6Val); many β⁰-thalassaemias = nonsense/frameshift. Frameshift arises from insertions/deletions not a multiple of three.

Key differentials / commonly confused pairs

• Transcription vs Translation: Transcription = DNA→RNA (nucleus, RNA polymerase); Translation = mRNA→protein (cytoplasm/ribosome).
• EF-Tu vs EF-G: EF-Tu/eEF-1 = delivers tRNA to A site (decoding); EF-G/eEF-2 = translocase. Diphtheria hits eEF-2.
• IF-2 (prokaryote) vs eIF-2 (eukaryote): both GTP-dependent initiator-tRNA carriers; eIF-2 is regulated by phosphorylation (stress response, HRI/PKR/PERK).
• fMet vs Met: fMet is prokaryotic initiator; the formyl group/Met is later cleaved.
• Shine-Dalgarno vs Kozak: ribosome-binding positioning in prokaryotes vs eukaryotes respectively.

Recently asked / exam angle

• "Wobble position" = 3′ base of codon / 5′ of anticodon; inosine pairs with U, C, A. Direct one-liner MCQ.
• Which enzyme is a ribozyme? → Peptidyl transferase (23S rRNA). Also asked: RNase P, self-splicing introns.
• Diphtheria toxin mechanism → ADP-ribosylation of eEF-2 (translocase). Pairs with Pseudomonas exotoxin A.
• Antibiotic–ribosomal site matching (30S vs 50S) — recurring image/grid question; chloramphenicol = peptidyl transferase is the trap.
• Number of high-energy bonds per peptide bond = 4.
• Stop codons / which codon initiates — straightforward recall; AUG = Met = start.
• Selenocysteine inserted at UGA — increasingly common "exception" item.
• ATP→AMP+PPi in tRNA charging (not ATP→ADP) — a classic distractor.
• Cycloheximide acts on eukaryotic (60S) ribosome — used to distinguish prokaryotic vs eukaryotic synthesis experimentally.
• Degenerate but unambiguous — conceptual statement framed as true/false.

Rapid revision

1. 64 codons: 61 sense + 3 stop (UAA, UAG, UGA); AUG = start = Met/fMet.
2. Code is triplet, non-overlapping, comma-less, degenerate, unambiguous, nearly universal, read 5′→3′.
3. Wobble at codon 3′ base; inosine pairs with U/C/A → fewer tRNAs needed.
4. Peptidyl transferase = 23S rRNA ribozyme; sites are A, P, E.
5. Charging: AA + tRNA + ATP → aminoacyl-tRNA + AMP + PPi; synthetases give a "second genetic code."
6. Prokaryote ribosome 70S (30S+50S); eukaryote 80S (40S+60S).
7. EF-Tu/eEF-1 = decoding; EF-G/eEF-2 = translocation; ~4 high-energy bonds per residue.
8. Initiation: prokaryote uses Shine-Dalgarno + fMet (IF-1,2,3); eukaryote uses 5′ cap scanning + eIF-2.
9. Termination by release factors (RF-1/2/3; eRF-1) recognising stop codons.
10. Chloramphenicol → peptidyl transferase; erythromycin → translocation; tetracycline → A site/30S; aminoglycoside → 30S misreading; cycloheximide → 60S.
11. Diphtheria & Pseudomonas exotoxin A → ADP-ribosylate eEF-2; ricin/Shiga → depurinate 28S rRNA; puromycin acts on both ribosomes.
12. Exceptions: mitochondrial UGA = Trp; selenocysteine (21st aa) inserted at UGA via SECIS; sickle cell = missense Glu6Val.